Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 193 publications
Hypertension Prevalence and Control at Trial Entry in the REPRIEVE Study Population: Results From a Secondary Analysis.
Journal: Open forum infectious diseases
Published: May 22, 2026
Pitavastatin effect on enterocyte injury markers in an ART treated HIV population: Insights from REPRIEVE.
Journal: AIDS (London, England)
Published: February 20, 2026
Heart Failure Risk and Events in People With HIV: The Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE).
Journal: Circulation. Heart failure
Published: December 29, 2025
Phase 1 trial of intranasal NDV-HXP-S in previously vaccinated adults.
Journal: Vaccine
Published: December 28, 2025
Baseline ECG and Cardiovascular Outcomes in People With HIV: Insights From REPRIEVE.
Journal: Journal of the American Heart Association
Published: December 11, 2025
Incidence, risk factors, and cardiovascular impact of hypertension in people with HIV: a secondary analysis of the REPRIEVE trial.
Journal: The lancet. HIV
Published: December 05, 2025
A tool based on objective data to identify patients at elevated risk of hospital-onset Staphylococcus aureus bacteremia: a nested case-control study.
Journal: Antimicrobial stewardship & healthcare epidemiology : ASHE
Published: November 11, 2025
Clonal Hematopoiesis and Major Adverse Cardiac Events in People With HIV: Insights From the REPRIEVE Trial.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: November 06, 2025
Safety and Immunogenicity of BNT162b2 in Antiretroviral Therapy-Treated People With HIV.
Journal: Open forum infectious diseases
Published: October 28, 2025
Last Updated: 09/26/2026